Transplantation, IsogeneicNiridazoleTransplantation, HomologousLiver TransplantationNeoplasm TransplantationKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraTreatment OutcomeImmunosuppressive AgentsGraft vs Host DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationTime FactorsTissue and Organ ProcurementRetrospective StudiesTransplantation ToleranceImmunosuppressionPeripheral Blood Stem Cell TransplantationLiver FailureTransplantation, HeterologousHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsMesenchymal Stem Cell TransplantationRecurrenceSkin TransplantationDisease Models, AnimalWaiting ListsHematologic NeoplasmsFollow-Up StudiesCorneal TransplantationSurvival AnalysisHistocompatibilitySurvival RateCyclosporineTacrolimusTissue TransplantationMice, Inbred C57BLWhole-Body IrradiationCadaverCombined Modality TherapyLiver DiseasesBrain Tissue TransplantationFacial TransplantationDonor SelectionOrgan PreservationGenetic TherapyKidney Failure, ChronicBusulfanPrognosisLeukemiaRisk FactorsTransplantsAcute DiseaseCells, CulturedRemission InductionHLA AntigensCell DifferentiationRats, Inbred LewLiverBronchiolitis ObliteransCell ProliferationHematopoietic Stem CellsT-LymphocytesAntilymphocyte SerumCyclophosphamideSignal TransductionMice, TransgenicHand TransplantationAnemia, AplasticBlood Group IncompatibilityMultiple MyelomaCytomegalovirus InfectionsMycophenolic AcidAntineoplastic AgentsDisease-Free SurvivalPostoperative PeriodMyeloablative AgonistsApoptosisProspective StudiesTissue and Organ HarvestingMice, Inbred BALB C